ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc (CRNX)

54.83
1.25
(2.33%)
Closed July 23 4:00PM
54.83
0.00
( 0.00% )
Pre Market: 8:31AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
54.83
Bid
51.81
Ask
74.00
Volume
40
0.00 Day's Range 0.00
15.76 52 Week Range 55.78
Market Cap
Previous Close
54.83
Open
-
Last Trade
40
@
55.02
Last Trade Time
06:00:00
Financial Volume
-
VWAP
-
Average Volume (3m)
921,668
Shares Outstanding
78,859,510
Dividend Yield
-
PE Ratio
-20.16
Earnings Per Share (EPS)
-2.72
Revenue
4.01M
Net Profit
-214.53M

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Crinetics Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRNX. The last closing price for Crinetics Pharmaceuticals was $54.83. Over the last year, Crinetics Pharmaceuticals shares have traded in a share price range of $ 15.76 to $ 55.78.

Crinetics Pharmaceuticals currently has 78,859,510 shares outstanding. The market capitalization of Crinetics Pharmaceuticals is $4.32 billion. Crinetics Pharmaceuticals has a price to earnings ratio (PE ratio) of -20.16.

CRNX Latest News

Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024...

Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2024, the Compensation Committee of Crinetics’ Board of Directors...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.530.9760589318654.355.7852.0683040153.64683176CS
410.4523.546642631844.3855.7841.0191164349.78048669CS
1211.0125.125513464243.8255.7841.0192166848.24697154CS
2617.1445.476253648237.6955.7835.784957245.19147107CS
5236.33196.37837837818.555.7815.76100558135.44345605CS
15634.83174.152055.7815.2355349929.46046718CS
26031.81138.18418766323.0255.7810.6338134427.75071009CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 4.26
(313.59%)
24.19M
DRMADermata Therapeutics Inc
$ 3.45
(165.38%)
20.02M
BBLGBone Biologics Corporation
$ 2.149
(71.92%)
8.85M
PIRSPieris Pharmaceuticals Inc
$ 13.65
(71.05%)
1.16M
HOTHHoth Therapeutics Inc
$ 1.43
(47.13%)
19.49M
CONNConns Inc
$ 0.3202
(-36.84%)
236.16k
NUWENewellis Inc
$ 2.76
(-33.49%)
73.39k
VWEVintage Wine Estates Inc
$ 0.0779
(-30.38%)
2.09M
VSTMVerastem Inc
$ 2.67
(-25.63%)
214.73k
ATPCAgape ATP Corporation
$ 0.16
(-25.58%)
869.51k
SLNASelina Hospitality PLC
$ 0.0259
(-0.38%)
41.4M
ALLRAllarity Therapeutics Inc
$ 0.2098
(26.01%)
38.06M
NUZENuZee Inc
$ 4.26
(313.59%)
24.19M
DRMADermata Therapeutics Inc
$ 3.45
(165.38%)
20.02M
HOTHHoth Therapeutics Inc
$ 1.43
(47.13%)
19.49M

Your Recent History

Delayed Upgrade Clock